Faculty

Institution

Unit

Venue

Asal Pilehvari

Assistant Professor of Public Health Sciences

University of Virginia

Affiliations

School of Medicine

Department of Public Health Sciences

Asal Pilehvari is currently serving as a Public Health Sciences Assistant Professor of Public Health Sciences at University of Virginia.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Asal Pilehvari

University of Virginia

Assistant Professor of Public Health Sciences

You can click a keyword to filter the displayed items

public health cancer care oncology medicine cancer treatment breast cancer health sciences epidemiology clinical research cancer research tobacco control breast oncology rural health metastasis anti-cancer agents cancer management medicinal research tobacco use enzyme inhibition health systems health care disparities social vulnerability index hormone receptor health care digital health cellular therapy cancer imaging community health health disparities health care costs ehealth cancer risk endocrine-related cancers endocrine oncology nicotine appalachian status multiple myeloma social vulnerability endocrine therapy real-world setting cell transplantation liver transplantation transplantation proceeding clinical transplantation bone marrow transplantation production economics economic analysis economic research clinical investigation social networks social gerontology bone marrow failure transplant surgery stem cell transplantation stem-cell therapy industrial policy growth theory privatization drug targeting insomnia pharmacoeconomics cost effectiveness rural economies rural sociology rural development health impact assessment health system analysis prevalence disparities virginia counties iran evidence productivity growth productivity trend multi-dimensional yost index maternal smoking socioeconomic disparities appalachian areas

Notable Scholarly Works

Notable Federal Grants

Collaborators

Clinical and Demographic Characteristics of Long-Term Responders to First-Line Endocrine Therapy Alone for Hormone Receptor Positive, Her2 Negative, Metastatic Breast Cancer. SSRN Electronic Journal (2026)

demographic characteristicsmedicineendocrine-related cancersmetastasiscancer careradiation oncologygynecologic oncologybreast canceroncologymetastatic breast cancerhormone receptorgynecologybreast oncology

Area Deprivation Index as a Predictor of Survival and Treatment Disparities in Older Adults With Acute Myeloid Leukemia: A Population-Based Study. Blood (2025)

health services researchsurvival analysisgeriatricsarea deprivation indexhealth care disparitiespublic healthcancer carehealth planningpopulation healthlife expectancytreatment disparitiesacute myeloid leukemiahealth policyleukemiageriatric medicinehealth systemscancer disparitiessupportive caremortality

Disparities in Treatment Delays Among Metastatic Breast Cancer Patients: Insights From Nationwide Electronic Health Records, 2011–2022. Breast Cancer Research and Treatment (2025)

Asal PilehvariWen YouGretchen KimmickGloribel BonillaRoger Anderson

public healthcancer carecancer researchepidemiologyhealth care disparitiesbreast oncologybiostatisticsbreast canceroncologyclinical researchtreatment delayscancer treatmentdigital healthehealthcancer disparities

Do Perceptions of Harm and Addictiveness Influence Adolescent's Willingness to Use Various Tobacco and Nicotine Products?. Tobacco Prevention & Cessation (2025)

Melissa A LittleIndika MallawaarachchiAsal PilehvariPonni VelmuruganAbigail G WesterKara P Wiseman

public healthsubstance abusetobacco policynicotine productsadolescent healthsubstance addictionbehavioral researchnicotinesubstance useaddictionnicotine productaddictive behaviorstobacco useharm reductionavailable tnpstobacco controlbehavioral sciences

Epr25-115: Pre-Menopausal Obesity Duration and Breast Cancer Risk in Women With Family History of Breast Malignancy. Journal of the National Comprehensive Cancer Network (2025)

Maria Reyes-MatosAsal PilehvariRoger Anderson

obesity medicinesurvival analysisearly life exposuresdietary exposurekidney cancerfamily historycohort studieswomen's healthcancer careretrospective cohort studiesbreast cancer riskbreast malignancyjama oncologyurologytumor biologyprospective cohort studiesimmunologygeneticsweight disordersoncologypre-menopausal obesity durationpediatric obesity

Factors Influencing the Use of the Text2Quit Feature in the Virginia Quitline Program. American Journal of Preventive Medicine (2025)

Asal PilehvariRebecca A KrukowskiKara P WisemanMelissa A Little

public healthhealth communicationprevention sciencepreventive healthcarevirginia quitline programpreventive medicinehealth preventiondisease preventionhealth sciencestobacco controlbehavior change (public health)public health interventions

Improved Survival With Sodium-Glucose Cotransporter-2 Inhibitors and Immune Checkpoint Inhibitors in Metastatic Solid Tumors.. Journal of Clinical Oncology (2025)

Sara YoungSean DoughertyHector PiconQingyi HeAsal PilehvariWen YouRichard HallMatthew Reilley

novel therapiestherapy resistancetherapeutic efficacytumor microenvironmentcancer biologymetastatic solid tumorssurgical oncologytumor suppressorscancer immunotherapytherapeutic targetstumor biologyimmunologypharmacologysystems biologycancer discoveryclinical researchoncogenesmedicinal researchcancer cells

The Cost-Effectiveness of Cdk4/6 Inhibitors in Treating Hr+/Her2− Metastatic Breast Cancer Patients in the USA: When Non-Medication Expenses Are Considered. Clinical Drug Investigation (2025)

Asal PilehvariWen YouGretchen KimmickFabian CamachoGloribel BonillaRoger Anderson

medicinecost effectivenesscancer carehealth care costscancer researchbreast cancerhealth economicsclinical researchoncologyclinical investigationcancer treatmentnon-medication expensespharmacoeconomics

The Expanding Role of Health Services Research in Cancer Prevention and Control. Health Services Research (2025)

public healthhealth services researchcancer carehealth planninghealth promotionpreventive healthcarehealth systemspreventive medicineexpanding rolehealth preventiondisease preventioncancer preventionhealth policy

Abstract Po1-17-12: The Impact of Treatment Sequence of Cdk4/6 Inhibitor Therapy on Metastatic Breast Cancer Treatment Outcomes in Real-World Practice in U.S. Cancer Research (2024)

Gretchen KimmickAsal PIlehvariWen YouGloribel BonillaRoger Anderson

metastasisreal-world practicebreast oncologymedicinecancer carecancer managementtreatment sequenceanti-cancer agentsbreast cancercancer biologycancer researchsurgical oncologycancer treatmentpharmacologyradiation oncologypharmacotherapycancer imagingoncologyclinical researchmedicinal research

1
2
3
4
10 / page

Asal Pilehvari

Assistant Professor of Public Health Sciences

University of Virginia

Affiliations

School of Medicine

Department of Public Health Sciences

Asal Pilehvari is currently serving as a Public Health Sciences Assistant Professor of Public Health Sciences at University of Virginia.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Asal Pilehvari

University of Virginia

Assistant Professor of Public Health Sciences

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Area Deprivation Index as a Predictor of Survival and Treatment Disparities in Older Adults With Acute Myeloid Leukemia: A Population-Based Study. Blood (2025)

Disparities in Treatment Delays Among Metastatic Breast Cancer Patients: Insights From Nationwide Electronic Health Records, 2011–2022. Breast Cancer Research and Treatment (2025)

Asal PilehvariWen YouGretchen KimmickGloribel BonillaRoger Anderson

Do Perceptions of Harm and Addictiveness Influence Adolescent's Willingness to Use Various Tobacco and Nicotine Products?. Tobacco Prevention & Cessation (2025)

Melissa A LittleIndika MallawaarachchiAsal PilehvariPonni VelmuruganAbigail G WesterKara P Wiseman

Epr25-115: Pre-Menopausal Obesity Duration and Breast Cancer Risk in Women With Family History of Breast Malignancy. Journal of the National Comprehensive Cancer Network (2025)

Maria Reyes-MatosAsal PilehvariRoger Anderson

Factors Influencing the Use of the Text2Quit Feature in the Virginia Quitline Program. American Journal of Preventive Medicine (2025)

Asal PilehvariRebecca A KrukowskiKara P WisemanMelissa A Little

Improved Survival With Sodium-Glucose Cotransporter-2 Inhibitors and Immune Checkpoint Inhibitors in Metastatic Solid Tumors.. Journal of Clinical Oncology (2025)

Sara YoungSean DoughertyHector PiconQingyi HeAsal PilehvariWen YouRichard HallMatthew Reilley

The Cost-Effectiveness of Cdk4/6 Inhibitors in Treating Hr+/Her2− Metastatic Breast Cancer Patients in the USA: When Non-Medication Expenses Are Considered. Clinical Drug Investigation (2025)

Asal PilehvariWen YouGretchen KimmickFabian CamachoGloribel BonillaRoger Anderson

The Expanding Role of Health Services Research in Cancer Prevention and Control. Health Services Research (2025)

Abstract Po1-17-12: The Impact of Treatment Sequence of Cdk4/6 Inhibitor Therapy on Metastatic Breast Cancer Treatment Outcomes in Real-World Practice in U.S. Cancer Research (2024)

Gretchen KimmickAsal PIlehvariWen YouGloribel BonillaRoger Anderson

1
2
3
4
10 / page

Similar Faculty Members

Roger Anderson

Institution

University of Virginia

health care disparities

cancer care

Ben Haaland

Institution

University of Utah

evidence-based medicine

health science

Seema Khan

Institution

Northwestern University

breast cancer

oncology

Vanessa B. Sheppard

Institution

Virginia Commonwealth University

public health

oncology

Steven Patierno

Institution

George Washington University

oncology

cancer research

Lisa Spees

Institution

University of North Carolina at Chapel Hill

health policy

health care delivery

Stephanie B. Wheeler

Institution

University of North Carolina at Chapel Hill

cancer care delivery

health policy

Karen Messer

Institution

University of California, San Diego

health policy

harm reduction

Susan Abughosh

Institution

University of Houston

health policy

harm reduction

Ji-Hyun Lee

Institution

University of Florida

clinical trials design

repeated measurements

Similar Faculty Members

Roger Anderson

Institution

University of Virginia

health care disparities

cancer care

Ben Haaland

Institution

University of Utah

evidence-based medicine

health science

Seema Khan

Institution

Northwestern University

breast cancer

oncology

Vanessa B. Sheppard

Institution

Virginia Commonwealth University

public health

oncology

Steven Patierno

Institution

George Washington University

oncology

cancer research

Lisa Spees

Institution

University of North Carolina at Chapel Hill

health policy

health care delivery

Stephanie B. Wheeler

Institution

University of North Carolina at Chapel Hill

cancer care delivery

health policy

Karen Messer

Institution

University of California, San Diego

health policy

harm reduction

Susan Abughosh

Institution

University of Houston

health policy

harm reduction

Ji-Hyun Lee

Institution

University of Florida

clinical trials design

repeated measurements